Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Non Operating Income (2020 - 2025)

BioAtla's Non Operating Income history spans 6 years, with the latest figure at -$1.0 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 6023.53% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached $1.2 million, down 44.28%, while the annual FY2025 figure was -$1.0 million, 11388.89% down from the prior year.
  • Non Operating Income reached -$1.0 million in Q4 2025 per BCAB's latest filing, down from $3000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.3 million in Q4 2023 to a low of -$1.0 million in Q4 2025.
  • Average Non Operating Income over 5 years is $680850.0, with a median of $43500.0 recorded in 2021.
  • Peak YoY movement for Non Operating Income: skyrocketed 48200.0% in 2023, then plummeted 6023.53% in 2025.
  • A 5-year view of Non Operating Income shows it stood at $1.0 million in 2021, then fell by 2.12% to $1.0 million in 2022, then soared by 517.99% to $6.3 million in 2023, then tumbled by 100.27% to -$17000.0 in 2024, then tumbled by 6023.53% to -$1.0 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Non Operating Income are -$1.0 million (Q4 2025), $3000.0 (Q3 2025), and -$64000.0 (Q2 2025).